Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.28 Analyst target: $7.00 Upside: 2420.71%
Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.